NCT05676060

Brief Summary

Review outcome of injection of facet joint in chronic low back pain

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

January 9, 2023

Status Verified

December 1, 2022

Enrollment Period

2 years

First QC Date

December 22, 2022

Last Update Submit

December 22, 2022

Conditions

Back Pain

Outcome Measures

Primary Outcomes (1)

  • Visual analogue scale

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between paints with similar conditions. VAS has been widely used in diverse adult populations

    Baseline

Interventions

quasiCOMBINATION_PRODUCT

block facet joint in back pain due to afacet cause

Also known as: facet block

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

individual

You may qualify if:

  • Focal tenderness over the facet joints
  • Low back pain with normal radiological findings,
  • Post-laminectomy syndrome with no evidence of arachnoiditis or recurrent disc disease,
  • Persistent low back pain after lumbar spinal 6- Failed conservative treatment, including physical therapy with exercises, chiropractic management, and pharmacologic therapy

You may not qualify if:

  • \- 1- Low back pain with abnormal radiological findings,
  • Post-laminectomy syndrome with evidence of arachnoiditis or recurrent disc disease,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Nada Tarek

CONTACT

01093906258nadatarek33332@gmail.com

Mohamed Ragaee

CONTACT

01011777288

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

December 22, 2022

First Posted

January 9, 2023

Study Start

January 1, 2023

Primary Completion

January 1, 2025

Study Completion

April 1, 2025

Last Updated

January 9, 2023

Record last verified: 2022-12